These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2583381)

  • 61. Interleukin-6 (IL-6)-597 A/G (rs1800797) & -174 G/C (rs1800795) gene polymorphisms in type 2 diabetes.
    Saxena M; Agrawal CG; Srivastava N; Banerjee M
    Indian J Med Res; 2014 Jul; 140(1):60-8. PubMed ID: 25222779
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome.
    Morotti E; Battaglia B; Fabbri R; Paradisi R; Venturoli S; Battaglia C
    Int J Fertil Steril; 2014 Jan; 7(4):301-12. PubMed ID: 24520500
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
    González F; Sia CL; Shepard MK; Rote NS; Minium J
    Hum Reprod; 2012 Dec; 27(12):3560-8. PubMed ID: 22940766
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
    González F; Sia CL; Shepard MK; Rote NS; Minium J
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4071-9. PubMed ID: 22904174
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women.
    González F; Nair KS; Daniels JK; Basal E; Schimke JM
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E297-306. PubMed ID: 22045316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evidence of proatherogenic inflammation in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    Metabolism; 2009 Jul; 58(7):954-62. PubMed ID: 19375763
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.
    Sam S; Sung YA; Legro RS; Dunaif A
    Metabolism; 2008 Jan; 57(1):84-9. PubMed ID: 18078863
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia.
    González F; Rote NS; Minium J; O'leary VB; Kirwan JP
    Obesity (Silver Spring); 2007 Oct; 15(10):2436-44. PubMed ID: 17925469
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.
    Corbould A; Dunaif A
    Metabolism; 2007 May; 56(5):716-22. PubMed ID: 17445549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.
    Sam S; Legro RS; Essah PA; Apridonidze T; Dunaif A
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7030-5. PubMed ID: 16632599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.
    Sam S; Legro RS; Bentley-Lewis R; Dunaif A
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4797-802. PubMed ID: 15899949
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Insulin resistance in polycystic ovary syndrome].
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Wien Klin Wochenschr; 2003 Dec; 115(23):812-21. PubMed ID: 14740344
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.
    Legro RS; Bentley-Lewis R; Driscoll D; Wang SC; Dunaif A
    J Clin Endocrinol Metab; 2002 May; 87(5):2128-33. PubMed ID: 11994352
    [TBL] [Abstract][Full Text] [Related]  

  • 74. International criteria for the diagnosis of diabetes and impaired glucose tolerance.
    Harris MI; Hadden WC; Knowler WC; Bennett PH
    Diabetes Care; 1985; 8(6):562-7. PubMed ID: 4075941
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.
    Harris MI; Hadden WC; Knowler WC; Bennett PH
    Diabetes; 1987 Apr; 36(4):523-34. PubMed ID: 3817306
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic criteria for diabetes mellitus in Japan--from a report of the Japan Diabetes Society (JDS) Committee on the Diagnosis of Diabetes Mellitus, 1982.
    Kosaka K
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S59-62. PubMed ID: 7859634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples.
    Modan M; Harris MI; Halkin H
    Diabetes; 1989 Dec; 38(12):1630-5. PubMed ID: 2583381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of WHO and NDDG criteria for impaired glucose tolerance.
    Motala AA; Omar MA
    Diabetes Res Clin Pract; 1994 Mar; 23(2):103-9. PubMed ID: 8070301
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.